Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drug interactions and the elderly]

C Le Jeunne1, F C Hugues

  • 1Service de Médecine Interne II et de Thérapeutique, Hôpital Laennec, Paris, France.

Therapie
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Contribution and limits of "OSCE", "long-case" and "global end-of-placement marking" as end-of-rotation assessment methods. Experience from two internal medicine wards].

La Revue de medecine interne·2022
Same author

[Association between psychiatric comorbidities and hospital length of stay in post-emergency internal medicine patients].

La Revue de medecine interne·2020
Same author

[Reliability and validity of a workbook for assessment of professional competencies of internal medicine residents].

La Revue de medecine interne·2019
Same author

Rituximab as first-line therapy for acquired haemophilia A: a single-centre 10-year experience.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

[Lymphocytic meningitis in a 70-year-old woman].

La Revue de medecine interne·2016
Same author

Colchicine: a simple and effective treatment for pericarditis in systemic lupus erythematosus? A report of 10 cases.

Lupus·2015
Same journal

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Therapie·2026
Same journal

Barriers to prescribing methylphenidate for adults with ADHD: A qualitative study.

Therapie·2026
Same journal

[Self-medication and its factors amongst Navymen aboard surface ships of the French Navy at sea: A descriptive study].

Therapie·2026
Same journal

Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge.

Therapie·2026
Same journal

Multiple HIV virological failures related to bictegravir-valproic acid interaction evidenced by therapeutic drug monitoring: A retrospective study.

Therapie·2026
Same journal

Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France.

Therapie·2026
See all related articles

Elderly individuals face significant risks from drug interactions due to polypharmacy and physiological changes. Systematic identification of these interactions is crucial to prevent adverse events in this vulnerable population.

Area of Science:

  • Gerontology
  • Clinical Pharmacology
  • Pharmacovigilance

Context:

  • Elderly individuals consume a high number of medications, averaging 5.6 prescriptions for those over 75.
  • Multiple comorbidities lead to consultations with various specialists, increasing prescription complexity.
  • Unreported self-prescriptions further exacerbate the risk of drug interactions.

Purpose:

  • To highlight the heightened vulnerability of the elderly population to adverse drug events.
  • To identify key factors contributing to drug interactions in older adults.
  • To emphasize the need for systematic screening of drug interactions in geriatric care.

Summary:

  • Physiological changes in the elderly, including altered pharmacokinetics, reduce their ability to compensate for drug effects, increasing blood concentrations.

Related Experiment Videos

  • Commonly implicated drugs include diuretics, NSAIDs, benzodiazepines, antiarrhythmics, cardiac glycosides, antihypertensives, and antidiabetics.
  • Clinical manifestations range from confusion and orthostatic hypotension to renal insufficiency and digestive issues.

    • Impact:

    • Increased susceptibility to drug side effects and toxicity in the elderly population.
    • Potential for severe clinical outcomes such as falls, cognitive impairment, and organ dysfunction.
    • Underscores the critical need for proactive and systematic management of polypharmacy in geriatric patients to ensure safety and improve health outcomes.